Maroteaux-Lamy Syndrome Stem Cell Treatments
A Regenerative Approach to a Rare Genetic Disorder
Maroteaux-Lamy syndrome (Mucopolysaccharidosis type VI, MPS VI) is a rare genetic condition caused by a deficiency of the enzyme arylsulfatase B, leading to the accumulation of glycosaminoglycans (GAGs) in tissues and organs. This buildup can result in skeletal deformities, joint stiffness, vision problems, and restricted growth.
At 1 STEM CELL, our regenerative therapy approach aims to complement traditional enzyme replacement therapy (ERT) by promoting cellular repair and tissue regeneration. The use of mesenchymal stem cells (MSCs) may help reduce inflammation, support enzyme activity, and improve organ and skeletal function over time.
While stem cell therapy is not a cure for MPS VI, ongoing research indicates that it may improve quality of life, enhance mobility, and reduce secondary complications related to inflammation and oxidative stress. Each treatment plan is personalized according to the patient’s clinical condition and response to therapy.
Questions and Answers About Maroteaux-Lamy Syndrome Stem Cell Treatments
Q: How can stem cells help patients with Maroteaux-Lamy syndrome?
Stem cells have anti-inflammatory and regenerative properties that may help reduce tissue damage caused by GAG accumulation and promote better organ function.
Q: Is stem cell therapy a replacement for enzyme replacement therapy (ERT)?
No. Stem cell therapy is considered a complementary approach to ERT, aiming to enhance its effects and provide broader systemic benefits.
Q: What types of stem cells are used in this treatment?
We use umbilical cord-derived mesenchymal stem cells (MSCs), which are ethically sourced and processed under strict quality and safety standards.
Q: How soon can improvements be noticed?
Some patients may experience gradual improvements in energy, mobility, and joint flexibility within a few weeks to months, depending on the severity of their condition.
Q: Is the treatment safe?
Yes. At 1 STEM CELL, all treatments are conducted in controlled medical environments using certified stem cell preparations and protocols.